Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

150 ARTÍCULOS , VIENDO DEL 106 AL 120

Association of Nutrients with Biomarkers of Alzheimer's Disease

Kalli EG.

Adv Exp Med Biol. 2017;987:257-268. doi: 10.1007/978-3-319-57379-3_23.

Search for Alzheimer's disease biomarkers in blood cells: hypotheses-driven approach

Wojsiat J, Laskowska-Kaszub K, Mietelska-Porowska A, Wojda U.

Biomark Med. 2017 Oct;11(10):917-931. doi: 10.2217/bmm-2017-0041. Epub 2017 Oct 4.

Alzheimer's disease and cytokine IL-10 gene polymorphisms: is there an association?

Magalhães CA, Carvalho MDG, Sousa LP, Caramelli P, Gomes KB.

Arq Neuropsiquiatr. 2017 Sep;75(9):649-656. doi: 10.1590/0004-282X20170110.

Memory Correlates of Alzheimer's Disease Cerebrospinal Fluid Markers: A Longitudinal Cohort Study

Reijs BLR, Ramakers IHGB, Köhler S, Teunissen CE, Koel-Simmelink M, Nathan PJ, Tsolaki M, Wahlund LO, Waldemar G, Hausner L, Vandenberghe R, Johannsen P, Blackwell A, Vanderstichele H, Verhey F, Visser PJ.

J Alzheimers Dis. 2017;60(3):1119-1128. doi: 10.3233/JAD-160766.

Exploring Erythrocytes as Blood Biomarkers for Alzheimer's Disease

Stevenson A, Lopez D, Khoo P, Kalaria RN, Mukaetova-Ladinska EB.

J Alzheimers Dis. 2017;60(3):845-857. doi: 10.3233/JAD-170363.

Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition

Reijs BLR, Ramakers IHGB, Elias-Sonnenschein L, Teunissen CE, Koel-Simmelink M, Tsolaki M, Wahlund LO, Waldemar G, Hausner L, Johannsen P, Vanderstichele H, Verhey F, Devanand DP, Visser PJ.

J Alzheimers Dis. 2017;60(3):1025-1034. doi: 10.3233/JAD-170564.

Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome

Caraci F, Iulita MF, Pentz R, Flores Aguilar L, Orciani C, Barone C, Romano C, Drago F, Cuello AC.

Eur J Pharmacol. 2017 Dec 15;817:7-19. doi: 10.1016/j.ejphar.2017.10.004. Epub 2017 Oct 5.

Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia

Frölich L, Peters O, Lewczuk P, Gruber O, Teipel SJ, Gertz HJ, Jahn H, Jessen F, Kurz A, Luckhaus C, Hüll M, Pantel J, Reischies FM, Schröder J, Wagner M, Rienhoff O, Wolf S, Bauer C, Schuchhardt J, Heuser I, Rüther E, Henn F, Maier W, Wiltfang J, Kornhuber J.

Alzheimers Res Ther. 2017 Oct 10;9(1):84. doi: 10.1186/s13195-017-0301-7.

Data Platform for the Research and Prevention of Alzheimer's Disease

An N, Jin L, Yang J, Yin Y, Jiang S, Jing B, Au R.

Adv Exp Med Biol. 2017;1028:55-78. doi: 10.1007/978-981-10-6041-0_4.

Preclinical effects of APOE ε4 on cerebrospinal fluid Aβ42 concentrations

Lautner R, Insel PS, Skillbäck T, Olsson B, Landén M, Frisoni GB, Herukka SK, Hampel H, Wallin A, Minthon L, Hansson O, Blennow K, Mattsson N, Zetterberg H.

Alzheimers Res Ther. 2017 Oct 23;9(1):87. doi: 10.1186/s13195-017-0313-3.

The Edinburgh Consensus: preparing for the advent of disease-modifying therapies for Alzheimer's disease

Ritchie CW, Russ TC, Banerjee S, Barber B, Boaden A, Fox NC, Holmes C, Isaacs JD, Leroi I, Lovestone S, Norton M, O'Brien J, Pearson J, Perry R, Pickett J, Waldman AD, Wong WL, Rossor MN, Burns A.

Alzheimers Res Ther. 2017 Oct 26;9(1):85. doi: 10.1186/s13195-017-0312-4.

Race modifies the relationship between cognition and Alzheimer's disease cerebrospinal fluid biomarkers

Howell JC, Watts KD, Parker MW, Wu J, Kollhoff A, Wingo TS, Dorbin CD, Qiu D, Hu WT.

Alzheimers Res Ther. 2017 Nov 2;9(1):88. doi: 10.1186/s13195-017-0315-1.

Recent Progress in the Pharmacotherapy of Alzheimer's Disease

Khoury R, Patel K, Gold J, Hinds S, Grossberg GT.

Drugs Aging. 2017 Nov;34(11):811-820. doi: 10.1007/s40266-017-0499-x.

18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)

Martínez G, Vernooij RW, Fuentes Padilla P, Zamora J, Flicker L, Bonfill Cosp X.

Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias